已收盘 04-02 16:00:00 美东时间
+0.055
+0.18%
BridgeBio Oncology Therapeutics Inc. announced late-breaking preclinical data on BBO-10203, a first-in-class covalent small molecule RAS:PI3Kα breaker, at the San Antonio Breast Cancer Symposium (SABC...
2025-12-11 05:05
Caris Life Sciences Inc. announced that it will present 19 studies at the upcoming 2025 San Antonio Breast Cancer Symposium (SABCS), scheduled for December 9-12, 2025. The studies, conducted in collab...
2025-12-04 21:30
Dec 1 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A: ACTINIUM PHARMACEUTICALS ANNOUNCES ATNM-400 DATA DEMONSTRATING POTENT EFFICACY IN TRIPLE-NEGATIVE BREAST CANCER AND ABILITY TO OVERCOME ENDOCRINE...
2025-12-01 21:52
Overview Olema reports Q3 net loss of $42.2 mln due to increased R&D expenses Company ends Q3 with $329 mln in cash and marketable securities Announced clinical trial agreement with Pfizer for palazes...
2025-11-10 20:15
Actinium Pharmaceuticals Inc. announced that new preclinical data for its lead antibody radioconjugate program, ATNM-400, will be presented at the 2025 San Antonio Breast Cancer Symposium (SABCS), sch...
2025-11-04 20:30
GREENBRAE, Calif., Dec. 19, 2023 /PRNewswire/ -- Alpha Blue Capital Management LP is pleased to announce the launch of Alpha Blue Capital US Small-Mid Cap Dynamic ETF listed on the NASDAQ wi...
2023-12-19 22:15